Skip to main content

Table 1 Baseline characteristics of patients

From: Platelet transfusions in cancer patients with hypoproliferative thrombocytopenia in the intensive care unit

Variables

296 patients

Age (years)

62 (53–70)

Male gender

196 (66 %)

Underlying malignancies

 Hematologic malignancies

242 (81.7 %)

  Acute leukemia

99 (33.4 %)

  Lymphoma

96 (32.4 %)

  Multiple myeloma

28 (9.4 %)

  Miscellaneous

19 (6.4 %)

 Solid tumors

54 (18.3 %)

  Uro-genital

17 (5.7 %)

  Digestive

15 (5 %)

  Pulmonary

9 (3 %)

  Breast

6 (2 %)

  Bone and cartilage

4 (1.3 %)

  Head and neck

4 (1.3 %)

Hematopoietic stem cell transplantation

42 (14.2 %)

Other comorbidities

 Chronic heart failure

61 (20.6 %)

 Chronic liver disease

13 (4.4 %)

 Chronic and end-stage renal failure

13 (4.4 %)

 Human immunodeficiency virus infection

6 (2 %)

 Solid organ transplantation

1 (0.3 %)

Anticoagulant and antiplatelet medications

69 (23.3 %)

 Prophylactic anticoagulant

21 (7.1 %)

 Curative anticoagulant

27 (9.1 %)

 Antiplatelet

21 (7.1 %)

Mechanisms of central thrombocytopenia

 Chemo- or radiotherapy-induced

223 (75.3 %)

 Bone marrow infiltration by malignant cells

55 (18.5 %)

 Hemophagocytosis

10 (3.4 %)

 Drug-induced (allergic)

4 (1.3 %)

 Myelofibrosis

4 (1.3 %)

  1. Variables are expressed as median (interquartile range) or number (percentage)